Status:
COMPLETED
The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy
Lead Sponsor:
Loma Linda University
Conditions:
Diabetic Neuropathy
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
The purpose of this graduate student research study is to explore the effects of a new treatment known as Intraneural facilitation (INF) on Diabetes Mellitus Type 2 (DMT2) subjects who have moderate -...
Detailed Description
The demographic data (age, height, gender, and weight) will be collected from each subject. All subjects will go through the following protocol: First, subjects will complete pre-testing measurements ...
Eligibility Criteria
Inclusion
- Patients with Diabetes Type 2 and Diabetic Peripheral Neuropathy with no other known underlying disease
- Below ankle Diabetic Peripheral Neuropathy symptoms (numbness, tingling, burning, sharp pain, increased sensitivity, etc.)
- ≥10 on Quality of Life- Diabetic Neuropathy Scale (QOL- DN)
- Between age 50-75 years
Exclusion
- Patients with a medical condition that suggested possible decline in function over the next 6 months such as; a current regimen of chemotherapy, radiation therapy, or dialysis
- Any lower extremity amputations or wounds
- Documented active alcohol and/or drug misuse
- Known health conditions: end stage renal failure, uncontrolled hypertension, severe dyslipidemia, chronic liver disease, autoimmune disease, advanced chronic obstructive pulmonary disease and active inflammations
- DM patients with inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy (CIDP), proximal diabetes neuropathy, and autonomic neuropathies
- Patients with other types of neuropathies not associated with Diabetes Mellitus such as B12 deficiency, hypothyroidism, and uremia
- Other severe chronic medical condition requiring active treatment
- Morbidly Obese patients
- Pregnancy (self reported)
Key Trial Info
Start Date :
September 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04025320
Start Date
September 27 2019
End Date
December 10 2020
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University
Loma Linda, California, United States, 92350